Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Plexus Corp’s disclosures can feel like assembling a multilayer circuit board—every footnote, customer-concentration table, and segment margin matters. Yet the company’s 10-K often exceeds 250 pages and its 8-K material events arrive without notice.
Stock Titan eliminates the guesswork. Our AI parses each Plexus SEC filing the moment it hits EDGAR, then delivers plain-English highlights so you can:
- See Plexus insider trading Form 4 transactions and receive Plexus Form 4 insider transactions real-time alerts.
- Compare backlog trends inside the Plexus quarterly earnings report 10-Q filing.
- Review supply-chain risk updates with our Plexus 8-K material events explained summaries.
Need to understand cost-plus defense contracts or how healthcare orders affect margins? Our AI-powered summaries point you straight to the notes that matter, making Plexus SEC filings explained simply.
For deeper dives, open the original documents beside concise annotations: the Plexus annual report 10-K simplified section decodes multi-segment revenue, while our proxy overview answers your search for Plexus proxy statement executive compensation. Investors tracking leadership moves can monitor Plexus executive stock transactions Form 4 without scanning dozens of PDFs.
Whether you’re researching contract manufacturing exposure or seeking a quick Plexus earnings report filing analysis, Stock Titan’s real-time data and expert context let you act with clarity, not guesswork.
InnovAge Holding Corp. (INNV) filed a Form 4 disclosing that director Edward M. Kennedy Jr. received 25,316 Restricted Stock Units (RSUs) on July 1, 2025. The award was recorded at a purchase price of $0 because RSUs are equity compensation rather than open-market purchases.
The RSUs will vest in full on June 30, 2026, provided the director remains in service through that date. Upon settlement, the units will convert into an equivalent number of common shares. Following the grant, Kennedy’s direct beneficial ownership totals 68,157 shares of InnovAge common stock.
No sales, option exercises, derivative positions, or other transactions were reported. The filing therefore reflects a routine equity-compensation grant that modestly increases insider alignment but does not involve immediate cash inflows, earnings information, or strategic developments.
FAQ
What is the current stock price of Plexus (PLXS)?
What is the market cap of Plexus (PLXS)?
What industries does Plexus Corp serve?
What is the core service model of Plexus Corp?
How does Plexus integrate various manufacturing services?
What sets Plexus apart from other EMS providers?
How extensive is Plexus Corp's global presence?
What quality control measures are implemented by Plexus Corp?
How do advanced technologies factor into Plexus' operations?
Does Plexus offer continued support after product commercialization?
